How Endometriosis Rewires the Brain's Natural Pain-Relief System
Endometriosis reduces opioid receptors (by 20%) and NMDA receptors (by 40%) in the brain's pain center without changing natural painkiller levels, potentially explaining why endometriosis pain is so hard to treat.
Quick Facts
What This Study Found
In a rat model of endometriosis, the condition caused significant changes in the brain's pain-processing center — the periaqueductal gray (PAG). After 60 days of endometriosis, mu opioid receptor (MOR) expression decreased by 20% and NMDA receptor (NR1) profiles decreased by 40% in the ventral PAG, despite no changes in endogenous opioid peptide levels (met-enkephalin, leu-enkephalin, and β-endorphin).
This means endometriosis doesn't reduce the brain's supply of natural painkillers — it reduces the receptors they need to work through. With fewer opioid receptors in the PAG, the brain's natural pain-dampening system becomes less effective, potentially explaining why endometriosis pain is so persistent and difficult to treat.
Key Numbers
60-day endometriosis model · 20% decrease in MOR-expressing neurons · 40% decrease in NR1-expressing neurons · No change in met-enkephalin, leu-enkephalin, or β-endorphin levels · Ventral PAG specifically affected
How They Did This
Researchers induced endometriosis in female Sprague-Dawley rats using the autotransplantation model (surgically relocating uterine tissue to create endometriotic lesions). After 60 days of disease progression, brain tissue was collected and the periaqueductal gray was analyzed using immunohistochemistry to quantify endogenous opioid peptides (met-enkephalin, leu-enkephalin, β-endorphin), mu opioid receptors, and NMDA NR1 receptor expression.
Why This Research Matters
Endometriosis affects an estimated 10% of reproductive-age women and is notorious for causing severe, chronic pain that responds poorly to standard treatments. This study reveals that endometriosis physically rewires the brain's pain-modulation circuitry by downregulating key receptors. Understanding this central sensitization mechanism could explain why opioid painkillers often become less effective over time in endometriosis patients and could guide the development of more targeted pain therapies.
The Bigger Picture
Chronic pain in endometriosis has traditionally been viewed as coming from the pelvic lesions themselves. This study adds to growing evidence that endometriosis causes central nervous system changes — the brain itself is altered. This concept of 'central sensitization' is reshaping how we understand and treat chronic pain conditions. It suggests that treating endometriosis pain may require addressing not just the pelvic disease but also the brain changes it causes.
What This Study Doesn't Tell Us
The autotransplantation rat model doesn't perfectly replicate human endometriosis — the disease originates differently and the hormonal milieu differs. The study examined a single timepoint (60 days) and didn't assess whether these brain changes correlate with behavioral pain measures. The sample size isn't stated in the abstract. Whether these receptor changes are reversible with endometriosis treatment is unknown.
Questions This Raises
- ?If endometriosis treatment removes the pelvic lesions, do the brain opioid receptor changes reverse, or has permanent central sensitization occurred?
- ?Could drugs that upregulate opioid receptor expression in the PAG provide more targeted pain relief for endometriosis patients?
- ?Does the 40% NMDA receptor reduction contribute to the well-documented difficulties with ketamine and other NMDA-targeting pain therapies in chronic pain patients?
Trust & Context
- Key Stat:
- 40% fewer pain receptors Endometriosis reduced NMDA receptor expression in the brain's pain-modulation center by 40%, revealing that the disease physically alters brain pain circuitry
- Evidence Grade:
- This is a well-designed animal study using a validated rat model of endometriosis with specific neuroanatomical and immunohistochemical analysis. While the mechanistic findings are compelling, translation from rat PAG to human pain processing involves uncertainty. The lack of behavioral pain correlation and unspecified sample sizes are limitations.
- Study Age:
- Published in 2016, this study was among the first to directly examine opioid receptor changes in the brain caused by endometriosis. The findings remain relevant and have been supported by subsequent research on central sensitization in endometriosis.
- Original Title:
- Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.
- Published In:
- Reproductive sciences (Thousand Oaks, Calif.), 23(9), 1158-67 (2016)
- Authors:
- Torres-Reverón, Annelyn, Palermo, Karylane, Hernández-López, Anixa, Hernández, Siomara, Cruz, Myrella L, Thompson, Kenira J, Flores, Idhaliz, Appleyard, Caroline B
- Database ID:
- RPEP-03134
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why is endometriosis pain so hard to treat?
This study reveals one important reason: endometriosis physically changes the brain's pain-processing system. The condition reduces opioid receptors (by 20%) and NMDA receptors (by 40%) in the brain's natural pain-control center, while endorphin levels remain normal. Your brain still makes its natural painkillers, but there are fewer receptors for them to work through — like trying to unlock doors when many of the locks have been removed.
Does this mean opioid painkillers won't work well for endometriosis?
The study suggests a biological basis for why opioid painkillers may become less effective over time in endometriosis. With 20% fewer mu opioid receptors in the pain center, both natural endorphins and opioid medications have fewer targets to act on. This supports the growing clinical consensus that endometriosis pain management should use multimodal approaches rather than relying primarily on opioid medications.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03134APA
Torres-Reverón, Annelyn; Palermo, Karylane; Hernández-López, Anixa; Hernández, Siomara; Cruz, Myrella L; Thompson, Kenira J; Flores, Idhaliz; Appleyard, Caroline B. (2016). Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.. Reproductive sciences (Thousand Oaks, Calif.), 23(9), 1158-67. https://doi.org/10.1177/1933719116630410
MLA
Torres-Reverón, Annelyn, et al. "Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray.." Reproductive sciences (Thousand Oaks, 2016. https://doi.org/10.1177/1933719116630410
RethinkPeptides
RethinkPeptides Research Database. "Endometriosis Is Associated With a Shift in MU Opioid and NM..." RPEP-03134. Retrieved from https://rethinkpeptides.com/research/torres-reveron-2016-endometriosis-is-associated-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.